Pretomanid in the Treatment of Patients with Tuberculosis in the United States
NEW ENGLAND JOURNAL OF MEDICINE(2022)
摘要
Pretomanid for MDR or XDR Tuberculosis Investigators report findings from the use of an all-oral regimen of bedaquiline, pretomanid, and linezolid in patients in the United States with multidrug-resistant or extensively drug-resistant tuberculosis.
更多查看译文
关键词
tuberculosis,treatment,patients
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要